U.S. market Closed. Opens in 11 hours 20 minutes

PHAR | Pharming Group N.V. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Revenue245.32M218.72M205.62M205.62M189.85M189.85M228.39M228.39M189.33M189.33M154.58M89.62M15.87M10.83M21.19M6.84M10.61M3.00M573.00K1.10M664.00K690.00K147.00K405.00K
Cost of Revenue25.21M24.37M17.56M17.56M20.18M20.18M25.34M25.34M23.92M23.92M25.37M12.45M4.68M4.80M3.43M1.11M4.27M3.53M91.00KN/AN/A25.31MN/A5.21M
Gross Profit220.10M194.35M188.06M188.06M169.67M169.67M203.06M203.06M165.41M165.41M129.20M77.17M11.19M6.03M17.76M5.73M6.35M-531.00K482.00KN/AN/A-24.62MN/A-4.81M
Operating Expenses242.11M218.85M169.83M169.83M156.72M156.72M120.97M120.97M97.19M97.19M85.74M55.26M22.73M18.86M14.88M12.64M22.55M17.93M23.92M28.74M25.95M-302.00K17.82M13.63M
Selling, General & Admin87.50M148.11M131.82M131.82M92.05M92.05M69.97M69.97M65.90M65.90M53.49M37.40M7.68M4.83M3.32M2.52M3.45M3.26M3.31M3.57M3.11M2.82M2.81M2.31M
Research & Development68.91M68.18M52.53M52.53M67.18M67.18M41.46M41.46M31.78M31.78M33.04M18.66M15.39M14.18M11.66M10.23M19.35M13.83M21.16M24.52M20.86M19.09M8.41M8.92M
Other Operating Expenses286.00KN/A-14.52M-14.52M-2.50M-2.50M9.54M9.54M-487.27K-487.27K-684.00K-790.00K-335.00K-147.00K-105.00K-106.00K-250.00K843.00K-555.00K647.00K1.98M-22.21M6.61M2.40M
Operating Income-5.39M-16.63M18.23M18.23M27.84M27.84M82.09M82.09M68.23M68.23M43.46M21.91M-11.54M-12.83M2.88M-6.91M-16.20M-18.47M-23.43M-27.65M-25.29M-24.32M-17.68M-18.44M
Other Expenses / Income12.43M5.30M-3.25M-3.25M-5.81M-5.81M-34.62M-34.62M-15.94M-15.94M-26.13M-111.31M-6.00M2.88M-8.64M-8.15M-7.89M623.00K-37.21M-4.08M-920.00K-11.57M-871.00K582.00K
Before Tax Income-12.01M-28.06M14.99M14.99M22.03M22.03M47.47M47.47M52.29M52.29M980.32K-89.40M-17.54M-9.96M-5.77M-15.06M-24.09M-17.84M-60.64M-31.72M-26.20M-35.89M-18.55M-17.86M
Income Tax Expenses-1.46M-6.01M1.31M1.31M6.76M6.76M6.83M6.83M11.74M11.74M-27.61M-9.44MN/AN/AN/AN/AN/AN/A-4.28M336.00KN/A-276.00K-51.00KN/A
Net Income-10.55M-22.05M13.67M13.67M15.27M16.00M34.39M37.75M45.49M40.54M28.59M-79.96M-17.54M-9.96M-5.77M-15.06M-24.09M-17.10M-56.37M-32.06M-26.20M-35.61M-18.50M-17.86M
Interest Expenses5.96M6.00M5.36M5.36M5.92M5.92M6.40M6.40M13.35M13.35M16.37M17.74M3.59M124.00K175.00K3.29M2.60M213.00K5.02M8.28M1.34M1.33M1.29M9.00K
Basic Shares Outstanding67.46MN/A64.87M70.71M64.20M70.12M63.63M68.27M62.63M67.35M65.35M50.04M41.54M41.17M39.61M21.46M7.35M4.74M2.68M1.17M923.46K915.95K868.02K797.91K
Diluted Shares Outstanding67.46MN/A70.71M70.71M70.12M70.12M68.27M68.27M67.35M67.35M65.35M50.04M41.54M41.17M39.61M21.46M7.35M4.74M2.68M1.17M923.46K915.95K868.02K797.91K
EBITDA-2.84M-13.40M32.61M32.61M46.56M46.56M92.11M92.11M75.41M75.41M50.98M-68.25M-13.19M-9.83M-5.59M-11.78M-21.50M-16.89M-55.63M-23.44M-23.44M-33.15M-16.04M-16.81M
EBITDA Margin-1.16%-6.13%15.86%15.86%24.52%24.52%40.33%40.33%39.83%39.83%32.98%-76.15%-83.12%-90.81%-26.39%-172.05%-202.56%-563.22%-9,707.85%-2,138.69%-3,529.97%-4,804.64%-10,914.29%-4,150.12%
EBIT-6.05M-22.06M20.34M20.34M27.95M28.67M47.62M50.98M70.59M65.64M17.35M-71.66M-13.95M-9.83M-5.59M-11.78M-21.50M-16.89M-55.63M-23.44M-24.86M-34.56M-17.25M-17.85M
EBIT Margin-2.47%-10.09%9.89%9.89%14.72%15.10%20.85%22.32%37.28%34.67%11.22%-79.96%-87.88%-90.81%-26.39%-172.05%-202.56%-563.22%-9,707.85%-2,138.69%-3,743.98%-5,008.70%-11,736.05%-4,407.41%
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312020-06-302019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙